Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
No Longer Available No phase listed Expanded access

AZD9291 US Expanded Access Program

ClinicalTrials.gov ID: NCT02451852

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT02451852. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 14, 2026, 9:01 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multi-center, AZD9291 Expanded Access Program for the Treatment of Patients With Advanced/Metastatic EGFR T790M Mutation-positive Non-small Cell Lung Cancer (NSCLC) Who Have Received Prior EGFR TKI Therapy

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To provide access to AZD9291 for adult patients with advanced/metastatic, epidermal growth factor receptor T790M mutation-positive non-small cell lung cancer.

Study identification

NCT ID
NCT02451852
Recruitment status
No Longer Available
Study type
Expanded access
Phase
Not listed
Lead sponsor
AstraZeneca
Industry
Enrollment
Not listed

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 130 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Not listed
Primary completion
Not listed
Completion
Not listed
Last update posted
Jul 14, 2016

United States locations

U.S. sites
32
U.S. states
19
U.S. cities
32
Facility City State ZIP Site status
Research Site Anaheim California — —
Research Site Beverly Hills California — —
Research Site Burbank California — —
Research Site Santa Barbara California — —
Research Site Santa Rosa California — —
Research Site Manchester Connecticut — —
Research Site Boca Raton Florida — —
Research Site Fleming Island Florida — —
Research Site Athens Georgia — —
Research Site Honolulu Hawaii — —
Research Site Chicago Illinois — —
Research Site Chevy Chase Maryland — —
Research Site Boston Massachusetts — —
Research Site Detroit Michigan — —
Research Site Lansing Michigan — —
Research Site Rochester Minnesota — —
Research Site Lincoln Nebraska — —
Research Site Paramus New Jersey — —
Research Site Buffalo New York — —
Research Site Fresh Meadows New York — —
Research Site Mineola New York — —
Research Site New York New York — —
Research Site Charlotte North Carolina — —
Research Site Winston-Salem North Carolina — —
Research Site Columbus Ohio — —
Research Site Sioux Falls South Dakota — —
Research Site Austin Texas — —
Research Site Dallas Texas — —
Research Site Fairfax Virginia — —
Research Site Warrenton Virginia — —
Research Site Lacey Washington — —
Research Site Seattle Washington — —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02451852, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 14, 2016 · Synced Nov 14, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.